ClinicalTrials.gg
CompletedNCT02924415FISTARUpdated Oct 5, 2016

Future Internet Social and Technological Alignment Research

An interventional study of Tele-care support and Control group in Bipolar Disorder, sponsored by Basque Health Service. Completed. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2016-10-05.

Sponsored by Basque Health Service · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

Bipolar disorder patients frequently presents recurring episodes and often experience subsyndromal symptoms, cognitive impairment and difficulties in the functioning with a low quality of life, relapses of disease and recurring hospitalization. Early diagnosis and appropriate intervention may play a role in preventing the neuroprogressive course of bipolar illness. The new technologies represent an opportunity to develop psychological standardized treatments using internet devices that minimizing the limitations of face to face treatments because of its accessibility that allow adjusting to the availability of each user. However, although exist many online psychological programs through web and mobile devices for bipolar disorder, there is not evidence about their efficacy and effectiveness due to the variability in measures and methodology used.

Read the detailed description

Future Internet Social and Technological Alignment Research (FI-STAR) clinical trial is a randomized simple blind evaluation within an European project. FISTAR is developed to compare this technical solution with treatment as usual. Bipolar disorder patients are to be included and randomly assigned to one of two treatment groups: 1) the experimental group (tele-care support) and the control group. Participants in both groups will be evaluated at baseline (pre-treatment) and at post-treatment.

02

Conditions studied

  • Bipolar Disorder

Browse trials for

03

In context

Bipolar Disorder

1,637 studies on the registry are indexed under Bipolar Disorder; 258 are open to participants now.

This study's enrollment of 50 is below the median of 63 across 1,245 interventional studies indexed under Bipolar Disorder.

Browse Bipolar Disorder studies →

Lead sponsor

Basque Health Service is the lead sponsor of 57 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having a diagnosis of bipolar disorder.
  • Being aged between 18-50 years.
  • Being in remission (euthymic state).
  • Being familiarity with new technologies (computer and /or smartphone).
  • Being treatment in the mental health network of the Basque Country (Osakidetza).

Exclusion criteria

Exclusion Criteria:

  • Having listening, reading or writing problems.
  • Having a diagnosis of mental retardation.
  • Unavailability of a smartphone.
  • Having manic or depressive symptomatology at the time of inclusion (HAMD> 16 and YOUNG> 8).
  • Having suicidal ideation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Tele-care support

    Online psychoeducation treatment using new technologies

    Behavioral: Tele-care support

  • Active comparator
    Control group

    Standard care

    Other: Control group

Interventions

  • BehavioralTele-care support

    Psychoeducation treatment based on telemedicine

  • OtherControl group

    Standard care

06

What researchers measure

Primary outcomes

  1. Functioning Assessment Short Test (FAST)

    To analyze the effectiveness of a psychoeducation treatment based on telemedicine versus usual treatment in relation with better functional outcome of bipolar disorder measured by Functioning Assessment Short Test.

    Time frame: baseline-9 weeks

Secondary outcomes

  1. Beck Depression Inventory (BDI-II)

    To analyze the improvement of depressive symptoms of patients measured by Beck Depression Inventory .

    Time frame: baseline-9 weeks

  2. State-Trait Anxiety Inventory (STAI)

    To analyze the improvement of anxiety symptoms of patients measured by State-Trait Anxiety Inventory .

    Time frame: baseline-9 weeks

  3. Young Mania Rating Scale (YMRS)

    To analyze the improvement of manic symptoms of patients measured by Young Mania Rating Scale .

    Time frame: baseline-9 weeks

  4. Treatment dropout rate

    To analyze satisfaction with the treatment received and the contact with the health service by treatment dropout rate.

    Time frame: baseline-9 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Gonzalez-Ortega I, Ugarte A, Ruiz de Azua S, Nunez N, Zubia M, Ponce S, Casla P, Llano JX, Faria A, Gonzalez-Pinto A. Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial. BMC Psychiatry. 2016 Dec 22;16(1):452. doi: 10.1186/s12888-016-1159-0. PubMed 28007034 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02924415
Lead sponsor
Basque Health Service
Responsible party
Ana María González-Pinto (Medical Doctor, Basque Health Service) — Principal investigator
First posted
Oct 5, 2016
Start date
Apr 2013
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Oct 5, 2016

Study contacts

Ana González-Pinto, MD
study chair · ANAMARIA.GONZALEZ-PINTOARRILLAGA@osakidetza.eus

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion